实验性R848佐剂疫苗接种后免疫应答的给药途径依赖性
研究比较了皮内与鼻内两种途径接种模型抗原(联合或不联合实验性佐剂及TLR7/8激动剂R848)后的免疫学结局。结果显示R848佐剂具有不依赖于给药途径的普遍免疫刺激作用,但两种途径在应答幅度和细胞因子谱上存在差异:皮内接种诱导的T细胞应答高于鼻内接种,而R848佐剂增强鼻内(而非皮内)T细胞活化后的IL-10和IL-17产生。
要点
- R848佐剂具有不依赖给药途径的免疫刺激作用,包括中性粒细胞、巨噬细胞和树突状细胞向引流淋巴结流入。
- 皮内和鼻内R848佐剂接种均主要诱导TH1应答,并引起引流淋巴结中CD11b+DC频率增加、CD103+DC相对丰度降低。
- 皮内接种诱导的T细胞应答高于鼻内接种,与皮内接种后抗原提呈细胞对抗原的局部摄取更高相对应。
核心结论
- R848佐剂具有不依赖给药途径的普遍免疫刺激作用,但皮内与鼻内接种在免疫应答幅度和细胞因子谱上存在差异。
- 皮内接种诱导的T细胞应答高于鼻内接种,与皮内接种后抗原提呈细胞局部摄取抗原更高相对应。
- R848佐剂增强鼻内(而非皮内)T细胞活化后的IL-10和IL-17产生,而皮内接种导致疫苗诱导T细胞的IL-10产生减少。
研究设计与样本
- 研究通过皮内和鼻内两种途径,联合或不联合实验性佐剂及TLR7/8激动剂R848,用模型抗原进行免疫,分析局部细胞募集、抗原提呈细胞摄取抗原及适应性应答启动。
主要发现
- R848佐剂引起中性粒细胞、巨噬细胞和树突状细胞向各自引流淋巴结流入,并增加抗原阳性抗原提呈细胞,皮内和鼻内接种均主要诱导TH1应答。
- 鼻内和皮内R848佐剂接种均引起引流淋巴结中CD11b+DC频率增加、CD103+DC相对丰度降低。
- 皮内接种诱导的T细胞应答高于鼻内接种,与皮内接种后抗原提呈细胞局部摄取抗原更高相对应。
- R848佐剂增强鼻内(而非皮内)T细胞活化后的IL-10和IL-17产生,皮内接种则导致疫苗诱导T细胞的IL-10产生减少。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Most traditional vaccines are administered via the intramuscular route. Other routes of administration however, can induce equal or improved protective memory responses and might provide practical advantages such as needle-free immunization, dose sparing and induction of tissue-specific (mucosal) immunity. Here we explored the differences in immunological outcome after immunization with model antigens via two promising immunization routes (intradermal and intranasal) with or without the experimental adjuvant and TLR7/8-agonist R848. Because the adaptive immune response is largely determined by the local innate cells at the site of immunization, the effect of R848-adjuvation on local cellular recruitment, antigenic uptake by antigen-presenting cells and the initiation of the adaptive response were analyzed for the two routes of administration. We show a general immune-stimulating effect of R848 irrespective of the route of administration. This includes influx of neutrophils, macrophages and dendritic cells to the respective draining lymph nodes and an increase in antigen-positive antigen-presenting cells which leads for both intradermal and intranasal immunization to a mainly TH1 response. Furthermore, both intranasal and intradermal R848-adjuvated immunization induces a local shift in DC subsets; frequencies of CD11b+DC increase whereas CD103+DC decrease in relative abundance in the draining lymph node. In spite of these similarities, the outcome of immune responses differs for the respective immunization routes in both magnitude and cytokine profile. Via the intradermal route, the induced T-cell response is higher compared to that after intranasal immunization, which corresponds with the local higher uptake of antigen by antigen-presenting cells after intradermal immunization. Furthermore, R848-adjuvation enhances ex vivo IL-10 and IL-17 production after intranasal, but not intradermal, T-cell activation. Quite the opposite, intradermal immunization leads to a decrease in IL-10 production by the vaccine induced T-cells. This knowledge may lead to a more rational development of novel adjuvanted vaccines administered via non-traditional routes.
引用
- van Aalst S, Jansen MAA, Ludwig IS, et al. Routing dependent immune responses after experimental R848-adjuvated vaccination. Vaccine. 2018. PMID: 29409680. doi:10.1016/j.vaccine.2018.01.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。